Connection
Wells Messersmith to Ligands
This is a "connection" page, showing publications Wells Messersmith has written about Ligands.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.030 |
|
|
|
-
Jimeno A, Gordon M, Chugh R, Messersmith W, Mendelson D, Dupont J, Stagg R, Kapoun AM, Xu L, Uttamsingh S, Brachmann RK, Smith DC. A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2017 Dec 15; 23(24):7490-7497.
Score: 0.030